(R)-4-氨基-2-甲基丁醇 | 88390-32-3

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: (R)-4-氨基-2-甲基丁醇
• 中文别名: (R)-4-氨基-2-甲基-1-丁醇；(R)-4-胺基-2-甲基丁醇
• 英文名称: (2R)-4-amino-2-methylbutan-1-ol
• 英文别名: (R)-4-amino-2-methyl-1-butanol
• CAS: 88390-32-3
• 化学式: C₅H₁₃NO
• 分子量: 103.164
• InChiKey: DUAXLVGFFDFSAG-RXMQYKEDSA-N

物化性质

• 沸点：
  80 °C / 1.8mmHg
• 密度：
  0,94 g/cm3

计算性质

• 辛醇/水分配系数(LogP)：
  -0.2
• 重原子数：
  7
• 可旋转键数：
  3
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  46.2
• 氢给体数：
  2
• 氢受体数：
  2

安全信息

• 危险类别码：
  R36/37/38
• 海关编码：
  2922199090
• 安全说明：
  S26,S36/37/39
• 储存条件：
  存放于惰性气体中，避免接触空气。

SDS

(R)-4-Amino-2-methyl-1-butanol Revision number: 1
SAFETY DATA SHEET

---

Section 1. BASE INFORMATION
Product name: (R)-4-Amino-2-methyl-1-butanol

Revision number: 1

---

Section 2. HAZARDS IDENTIFICATION
Classification of the GHS
PHYSICAL HAZARDS
Flammable liquids Category 4
HEALTH HAZARDS
Skin corrosion/irritation Category 2
Category 2A
Serious eye damage/eye irritation
ENVIRONMENTAL HAZARDS Not classified
GHS label elements
Pictograms or hazard symbols
Signal word Warning
Hazard statement Combustible liquid
Causes skin irritation
Causes serious eye irritation
Precautionary statements
[Prevention] Keep away from flames and hot surfaces.
Wash hands thoroughly after handling.
Wear protective gloves and eye/face protection.
IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses,
[Response]
if present and easy to do. Continue rinsing.
If eye irritation persists: Get medical advice/attention.
IF ON SKIN: Gently wash with plenty of soap and water.
If skin irritation occurs: Get medical advice/attention.
Take off contaminated clothing and wash before reuse.
Store in a well-ventilated place. Keep cool.
[Storage]
[Disposal] Dispose of contents/container through a waste management company authorized by
the local government

---

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substance/mixture: Substance
Component(s): (R)-4-Amino-2-methyl-1-butanol
>98.0%(GC)(T)
Percent:
CAS Number: 88390-32-3
Chemical Formula: C5H13NO
(R)-4-Amino-2-methyl-1-butanol

---

Section 4. FIRST AID MEASURES
Inhalation: Remove victim to fresh air and keep at rest in a position comfortable for breathing.
Get medical advice/attention if you feel unwell.
Skin contact: Remove/Take off immediately all contaminated clothing. Gently wash with plenty of
soap and water. If skin irritation or rash occurs: Get medical advice/attention.
Eye contact: Rinse cautiously with water for several minutes. Remove contact lenses, if present
and easy to do. Continue rinsing. If eye irritation persists: Get medical
advice/attention.
Ingestion: Get medical advice/attention if you feel unwell. Rinse mouth.
A rescuer should wear personal protective equipment, such as rubber gloves and air-
Protection of first-aiders:
tight goggles.

---

Section 5. FIRE-FIGHTING MEASURES
Suitable extinguishing Dry chemical, foam, carbon dioxide.
media:
Extinguishing media not to Water (It may scatter and spread fire.)
be used:
Specific hazards: Take care as it may decompose upon combustion or in high temperatures to
generate poisonous fume.
Specific methods: Fire-extinguishing work is done from the windward and the suitable fire-extinguishing
method according to the surrounding situation is used. Uninvolved persons should
evacuate to a safe place. In case of fire in the surroundings: Remove movable
containers if safe to do so.
Special protective When extinguishing fire, be sure to wear personal protective equipment.
equipment for firefighters:

---

Section 6. ACCIDENTAL RELEASE MEASURES
Personal precautions, Use personal protective equipment. Keep people away from and upwind of spill/leak.
protective equipment and Ensure adequate ventilation. Entry to non-involved personnel should be controlled
emergency procedures: around the leakage area by roping off, etc.
Environmental precautions: Prevent product from entering drains.
Methods and materials for Absorb spilled material in a suitable absorbent (e.g. rag, dry sand, earth, saw-dust).
containment and cleaning In case of large amount of spillage, contain a spill by bunding. Adhered or collected
up: material should be promptly disposed of, in accordance with appropriate laws and
regulations.
Prevention of secondary Remove all sources of ignition. Fire-extinguishing devices should be prepared in
hazards: case of a fire. Use spark-proof tools and explosion-proof equipment.

---

Section 7. HANDLING AND STORAGE
Handling
Technical measures: Handling is performed in a well ventilated place. Wear suitable protective equipment.
Prevent generation of vapor or mist. Keep away from flames and hot surfaces. Take
measures to prevent the build up of electrostatic charge. Use explosion-proof
equipment. Wash hands and face thoroughly after handling.
Use a closed system, ventilation.
Avoid contact with skin, eyes and clothing.
Advice on safe handling:
Storage
Storage conditions: Keep container tightly closed. Store in a cool, dark and well-ventilated place.
Store under inert gas.
Store away from incompatible materials such as oxidizing agents.
Packaging material: Law is followed.

---

Section 8. EXPOSURE CONTROLS / PERSONAL PROTECTION
Install a closed system or local exhaust as possible so that workers should not be
Engineering controls:
exposed directly. Also install safety shower and eye bath.
Personal protective equipment
Respiratory protection: Vapor respirator. Follow local and national regulations.
(R)-4-Amino-2-methyl-1-butanol

---

Section 8. EXPOSURE CONTROLS / PERSONAL PROTECTION
Hand protection: Protective gloves.
Eye protection: Safety glasses. A face-shield, if the situation requires.
Skin and body protection: Protective clothing. Protective boots, if the situation requires.

---

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Physical state (20°C): Liquid
clear
Form:
Color: Colorless - Slightly pale yellow
Odor: No data available
pH: No data available
Melting point/freezing point:No data available
Boiling Point/Range: 80 °C/0.2kPa
Flash Point: No data available
Explosive limits
No data available
Lower:
Upper: No data available
Density: 0.94
Solubility: No data available

---

Section 10. STABILITY AND REACTIVITY
Stability: Stable under proper conditions.
Reactivity: No special reactivity has been reported.
Conditions to avoid: Air-sensitive
Incompartible materials: oxidizing agents
Hazardous Decomposition Carbon monoxide, Carbon dioxide, Nitrogen oxides (NOx)
Products:

---

Section 11. TOXICOLOGICAL INFORMATION
Acute Toxicity: No data available
Skin corrosion/irritation: No data available
Serious eye No data available
damage/irritation:
Germ cell mutagenicity: No data available
Carcinogenicity:
IARC = No data available
No data available
NTP =
Reproductive toxicity: No data available

---

Section 12. ECOLOGICAL INFORMATION
Ecotoxicity:
Fish: No data available
Crustacea: No data available
No data available
Algae:
Persistence / degradability: No data available
No data available
Bioaccumulative
potential(BCF):
Mobillity in soil
log Pow: No data available
Soil adsorption (Koc): No data available
Henry's Law No data available
constant(PaM3/mol):

---

Section 13. DISPOSAL CONSIDERATIONS
Recycle to process, if possible. Consult your local regional authorities. You may be able to burn in a chemical
incinerator equipped with an afterburner and scrubber system. Observe all federal, state and local regulations when
disposing of the substance.
(R)-4-Amino-2-methyl-1-butanol

---

Section 14. TRANSPORT INFORMATION
Hazards Class: Does not correspond to the classification standard of the United Nations
UN-No: Not Listed

---

Section 15. REGULATORY INFORMATION
Safe management ordinance of dangerous chemical product (State Council announces on January 26,
2002): Safe use and production, the storage of a dangerous chemical, transport, loading and unloading were
prescribed.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  (R)-4-氨基-2-甲基丁醇 在 sodium tetrahydroborate 作用下， 以 甲醇 为溶剂， 反应 3.5h， 生成 (R)-N-benzyl-4-hydroxy-3-methylbutan-1-amine
  参考文献：
  名称：

  [Co（TPP）]-取代哌啶的催化形成

  摘要：

  通过钴（III）-卡宾自由基中间体进行的自由基环化是合成（杂环）环状结构的有力方法。以最近报道的Co II催化的五元N-杂环吡咯烷的合成为基础卟啉，本文介绍了直接由线性醛类[Co（TPP）]催化形成的有用的六元N-杂环哌啶。以总的高收率获得哌啶，并以少量副产物形式形成直链烯烃。进行了DFT研究，以更深入地了解钴（II）-卟啉催化的吡咯烷，哌啶和线性烯烃的形成。计算表明，烯烃不可能通过预期的1,2-氢原子转移至卡宾碳而形成。取而代之的是，该计算与涉及苄基自由基形成，随后进行自由基反弹的闭环形成哌啶的途径是一致的。竞争性1

  DOI：

  10.1002/chem.201900587
• 作为产物：
  描述：

  仲丁醇 以 水 为溶剂， 生成 (R)-4-氨基-2-甲基丁醇
  参考文献：
  名称：

  EP1219593

  摘要：

  公开号：

文献信息

• Highly Chemoselective Aerobic Oxidation of Amino Alcohols into Amino Carbonyl Compounds
  作者：Yusuke Sasano、Shota Nagasawa、Mai Yamazaki、Masatoshi Shibuya、Jaiwook Park、Yoshiharu Iwabuchi

  DOI：10.1002/anie.201309634

  日期：2014.3.17

  direct oxidation of unprotected amino alcohols to their corresponding amino carbonyl compounds has often posed serious challenges in organic synthesis and has constrained chemists to adopting an indirect route, such as a protection/deprotection strategy, to attain their goal. Described herein is a highly chemoselective aerobic oxidation of unprotected amino alcohols to their amino carbonyl compounds

  未保护的氨基醇直接氧化成其相应的氨基羰基化合物经常在有机合成中面临严峻挑战，并限制了化学家采用间接路线（例如保护/脱保护策略）来实现其目标。本文描述了未保护的氨基醇对它们的氨基羰基化合物的高度化学选择性好氧氧化，其中使用了2-氮杂金刚烷N-氧基（AZADO）/铜催化。所开发的催化系统导致带有伯，仲或叔氨基的各种未保护氨基醇的醇选择性氧化，在环境温度下暴露于空气下具有良好至高收率，从而为合成氮提供了灵活性。含有化合物。
• [EN] APOPTOSIS SIGNAL-REGULATING KINASE INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE KINASE DE RÉGULATION DU SIGNAL DE L'APOPTOSE ET LEURS UTILISATIONS
  申请人：FRONTHERA U S PHARMACEUTICALS LLC

  公开号：WO2019051265A1

  公开（公告）日：2019-03-14

  Described herein are ASK1 inhibitors and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of blood disease, autoimmune disorders, pulmonary disorders, hypertension, inflammatory diseases, fibrotic diseases, diabetes, diabetic nephropathy, renal diseases, respiratory diseases, cardiovascular diseases, acute lung injuries, acute or chronic liver diseases, and neurodegenerative diseases.

  本文描述了ASK1抑制剂和包含该化合物的药物组合物。所述化合物和组合物对于治疗血液疾病、自身免疫性疾病、肺部疾病、高血压、炎症性疾病、纤维化疾病、糖尿病、糖尿病肾病、肾脏疾病、呼吸系统疾病、心血管疾病、急性肺损伤、急性或慢性肝病以及神经退行性疾病具有用处。
• Synthesis and Application of a New Bisphosphite Ligand Collection for Asymmetric Hydroformylation of Allyl Cyanide
  作者：Christopher J. Cobley、Kelli Gardner、Jerzy Klosin、Céline Praquin、Catherine Hill、Gregory T. Whiteker、Antonio Zanotti-Gerosa、Jeffrey L. Petersen、Khalil A. Abboud

  DOI：10.1021/jo040128p

  日期：2004.6.1

  auxiliary and screened in the asymmetric hydroformylation of allyl cyanide. These hydroformylation results were compared with those of two existing chiral ligands, Chiraphite and BINAPHOS, whose utility in asymmetric hydroformylation has been previously demonstrated. Bisphosphite 11 with a 2,2‘-biphenol bridge was found to be the best overall ligand for asymmetric hydroformylation of allyl cyanide with up

  用（S）-5,5'，6,6'-四甲基-3,3'-二叔叔丁基-1,1'-联苯-2,2'-制备了一系列单亚磷酸酯和亚磷酸酯亚磷酸酯二氧基[（S）-BIPHEN]作为手性助剂，并在烯丙基氰化物的不对称加氢甲酰化反应中进行了筛选。将这些加氢甲酰化的结果与两个现有的手性配体Chiraphite和BINAPHOS的结果进行了比较，后者已在不对称加氢甲酰化中得到了证明。发现具有2,2'-双酚桥的双亚磷酸酯11是烯丙基氰化物不对称加氢甲酰化的最佳整体配体，ee高达80％ee，区域选择性（分支线性比，b / l）为20，且具有翻转频率的625 [h - 1]在35°C下。当反应在丙酮或纯净条件下进行时，BINAPHOS的对映选择性高达77％ee，但区域选择性差（b / l 2.8），活性比11低7倍。随后将使用（R，R）-11的烯丙基氰化物加氢甲酰化产物转化为（R）-2-甲基-4-氨基丁醇，一种有用的手性结
• ESTRA-1,3,5(10),16-TETRAENE-3-CARBOXAMIDES FOR INHIBITION OF 17.BETA.-HYDROXYSTEROID DEHYDROGENASE (AKR1 C3)
  申请人：BAYER PHARMA AKTIENGESELLSCHAFT

  公开号：US20160024142A1

  公开（公告）日：2016-01-28

  The invention relates to AKR1C3 inhibitors of formula (I) and to processes for preparation thereof, to the use thereof for treatment and/or prophylaxis of diseases and to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially of bleeding disorders and endometriosis.

  该发明涉及式(I)的AKR1C3抑制剂，以及其制备方法，用于治疗和/或预防疾病，以及用于生产治疗和/或预防疾病的药物，特别是出血性疾病和子宫内膜异位症。
• [EN] NEW MACROCYCLIC COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM<br/>[FR] NOUVEAUX COMPOSÉS MACROCYCLIQUES, LEUR PROCÉDÉ DE PRÉPARATION ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT
  申请人：SERVIER LAB

  公开号：WO2021170774A1

  公开（公告）日：2021-09-02

  A compound of formula (I) : wherein Z, Y1,Y2,(Formula II)R1 to R7 are as defined in the description, its optical isomers, and addition salts thereof with a pharmaceutically acceptable base. Medicaments.

  式（I）的化合物：其中Z，Y1，Y2，（式II）R1至R7如描述中所定义，其光学异构体，以及与药学上可接受的碱形成的加合盐。药物。

表征谱图